X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform.

Kevin Achberger | Christopher Probst | Jasmin Haderspeck | Sylvia Bolz | Julia Rogal | Johanna Chuchuy | Marina Nikolova | Virginia Cora | Lena Antkowiak | Wadood Haq | Nian Shen | Katja Schenke-Layland | Marius Ueffing | Stefan Liebau | Peter Loskill
eLife | 2019

The devastating effects and incurable nature of hereditary and sporadic retinal diseases such as Stargardt disease, age-related macular degeneration or retinitis pigmentosa urgently require the development of new therapeutic strategies. Additionally, a high prevalence of retinal toxicities is becoming more and more an issue of novel targeted therapeutic agents. Ophthalmologic drug development, to date, largely relies on animal models, which often do not provide results that are translatable to human patients. Hence, the establishment of sophisticated human tissue-based in vitro models is of upmost importance. The discovery of self-forming retinal organoids (ROs) derived from human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) is a promising approach to model the complex stratified retinal tissue. Yet, ROs lack vascularization and cannot recapitulate the important physiological interactions of matured photoreceptors and the retinal pigment epithelium (RPE). In this study, we present the retina-on-a-chip (RoC), a novel microphysiological model of the human retina integrating more than seven different essential retinal cell types derived from hiPSCs. It provides vasculature-like perfusion and enables, for the first time, the recapitulation of the interaction of mature photoreceptor segments with RPE in vitro. We show that this interaction enhances the formation of outer segment-like structures and the establishment of in vivo-like physiological processes such as outer segment phagocytosis and calcium dynamics. In addition, we demonstrate the applicability of the RoC for drug testing, by reproducing the retinopathic side-effects of the anti-malaria drug chloroquine and the antibiotic gentamicin. The developed hiPSC-based RoC has the potential to promote drug development and provide new insights into the underlying pathology of retinal diseases.

Pubmed ID: 31451149 RIS Download

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Covance (tool)

RRID:SCR_001224

A contract research organization providing drug development and animal testing services. Under the name Covance Research Products Inc., based in Denver, Pennsylvania, the company also deals in the import, breeding and sale of laboratory animals. It breeds dogs, rabbits, guinea pigs, non-human primates, and pigs, and runs the largest non-human primate laboratory in Germany. (Wikipedia)

View all literature mentions

PeproTech (tool)

RRID:SCR_006802

An Antibody supplier

View all literature mentions

Millipore (tool)

RRID:SCR_008983

An Antibody supplier

View all literature mentions

Abcam (tool)

RRID:SCR_012931

A commercial antibody supplier which supplies primary and secondary antibodies, biochemicals, proteins, peptides, lysates, immunoassays and other kits.

View all literature mentions

BD Biosciences (tool)

RRID:SCR_013311

An Antibody supplier

View all literature mentions

Chx10 (N-18) (antibody)

RRID:AB_2216006

This polyclonal targets VSX2

View all literature mentions

rhodopsin (1D4) (antibody)

RRID:AB_785511

This monoclonal targets rhodopsin (1D4)

View all literature mentions

PKC alpha (C-20) (antibody)

RRID:AB_2168668

This polyclonal targets PRKCA, PRKCG, PRKCB

View all literature mentions

Melanoma antibody [HMB45] (antibody)

RRID:AB_306146

This monoclonal targets Melanoma

View all literature mentions

Ezrin Antibody (antibody)

RRID:AB_2100309

This unknown targets Ezrin

View all literature mentions

CRALBP antibody [B2] (antibody)

RRID:AB_2269474

This monoclonal targets Rlbp1

View all literature mentions

Brn-3b (H-18) (antibody)

RRID:AB_2167523

This polyclonal targets Brn-3b (H-18)

View all literature mentions

AP-2alpha (3B5) (antibody)

RRID:AB_667767

This monoclonal targets TFAP2A

View all literature mentions

Arrestin-C (I-17) (antibody)

RRID:AB_2060084

This polyclonal targets Arrestin-C (I-17)

View all literature mentions

COMSOL Multiphysics (software resource)

RRID:SCR_014767

General-purpose software platform for modeling and simulating physics-based problems which accounts for coupled or multiphysics phenomena. The platform includes a set of core physics interfaces for common physics application areas such as structural analysis, laminar flow, pressure acoustics, transport of diluted species, electrostatics, electric currents, heat transfer, and Joule heating.

View all literature mentions

Fiji (software resource)

RRID:SCR_002285

Software package as distribution of ImageJ and ImageJ2 together with Java, Java3D and plugins organized into coherent menu structure. Used to assist research in life sciences.

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions